(Q44080580)

29 November 2017

title

Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease (English)

1 reference

non-alcoholic fatty liver

29 November 2017

1 reference

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

Hui Fan

1

1 reference

29 November 2017

QingRong Pan

series ordinal

2

1 reference

29 November 2017

Yuan Xu

series ordinal

3

1 reference

29 November 2017

XinChun Yang

series ordinal

4

1 reference

29 November 2017

publication date

1 December 2013

1 reference

Arquivos Brasileiros de Endocrinologia e Metabologia

29 November 2017

published in

1 reference

29 November 2017

volume

57

1 reference

29 November 2017

issue

9

1 reference

29 November 2017

page(s)

702-708

1 reference

Nonalcoholic fatty liver disease: a clinical review

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

Prevalence of diabetes among men and women in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

Insulin signaling to hepatic lipid metabolism in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

Medical treatment of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

Medical Consequences of Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

Glucagon-like peptide-1 analogues for Type 2 diabetes mellitus: current and emerging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000900005

10.1590/S0004-27302013000900005

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference